Keros Therapeutics
KROS
#8813
Rank
โ‚ฌ0.18 B
Marketcap
9,26ย โ‚ฌ
Share price
-0.38%
Change (1 day)
-21.13%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2026 (TTM): โ‚ฌ28.21 Million

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ29.08 Million. In 2025 the company made a revenue of โ‚ฌ0.20 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ3.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ28.21 M-86.42%
2025 โ‚ฌ0.20 B5990.07%
2024 โ‚ฌ3.41 M2397.5%
2023 โ‚ฌ0.13 M
2022 N/A-100%
2021 โ‚ฌ17.74 M
2020 N/A-100%
2019 โ‚ฌ8.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA